Literature DB >> 7012999

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes.

P J McDonald, B L Wetherall, H Pruul.   

Abstract

Exposure of Escherichia coli and Staphylococcus aureus to high levels of certain antibiotics for brief periods of time increases the susceptibility of the organisms to the antimicrobial action of normal human leukocytes. The degree of sensitization varies with the antibiotic used for the pretreatment of the bacteria and is most pronounced in pretreatment of E. coli with chloramphenicol. Studies on the rates of phagocytosis and intracellular killing of E. coli indicate that the postantibiotic leukocyte enhancement effect operates through increased susceptibility of antibiotic-damaged bacteria to the intracellular killing mechanisms of leukocytes. These observations may explain the efficacy of antimicrobial dosage regimens in which drug levels are below inhibitory concentrations for part of the dosage interval.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012999     DOI: 10.1093/clinids/3.1.38

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  53 in total

1.  Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains.

Authors:  A Novelli; S Fallani; M I Cassetta; S Conti; T Mazzei
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 2.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 3.  Continuous infusion of beta-lactam antibiotics.

Authors:  W A Craig; S C Ebert
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 4.  Setting and revising antibacterial susceptibility breakpoints.

Authors:  John Turnidge; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

5.  Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.

Authors:  J Renneberg; M Walder
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

6.  Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

7.  Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro.

Authors:  M R Yeaman; P M Sullam; P F Dazin; A S Bayer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Detection and partial characterization of antibacterial factor(s) in alveolar lining material of rats.

Authors:  J D Coonrod; K Yoneda
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

9.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

10.  Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.

Authors:  L Horgen; A Jerome; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.